Nationwide incidence of clinically diagnosed retinal vein occlusion in Korea, 2008 through 2011: preponderance of women and the impact of aging.

OBJECTIVE This study aimed at defining the incidence and demographics of clinically diagnosed retinal vein occlusion (RVO) in Korea. DESIGN Nationwide population-based retrospective study using data entered into the Korean national health claims database from 2007 through 2011. PARTICIPANTS Data of the entire population of Korea (n = 47,990,761, based on the 2010 census) were analyzed. METHODS The Korean national health claims database was analyzed to identify patients with RVO. Incident cases included individuals with no RVO claims in 2007, but with RVO claims in the years 2008 through 2011. The incidence rate of RVO was estimated for the entire Korean population. MAIN OUTCOME MEASURES The person-time incidence rates of clinically diagnosed RVO in Korea, including the age- and gender-specific incidence rates, were estimated. RESULTS A total of 92 730 RVO cases (56.4% in women) were identified. The incidence rate of clinically diagnosed RVO during the study period was 48.31 per 100,000 person-years (95% confidence interval [CI], 48.00-48.62). The incidence rate among men and women was 42.40 (95% CI, 41.99-42.81) and 54.14 (95% CI, 53.67-54.60) per 100,000 person-years, respectively (P < 0.001). The highest incidence of 214.92 per 100,000 person-years (95% CI, 211.29-218.56) was observed in the age group of 70 to 74 years (186.62 [95% CI, 181.46-191.78] and 236.25 [95% CI, 231.21-241.29] per 100,000 person-years for men and women aged 70 to 74 years, respectively). The incidence rate of RVO increased as the age of the population increased-more than doubling approximately every 10 years from the second to the seventh decade of life. Retinal vein occlusion occurred more often in men 30 to 54 years of age and in men older than 85 years, but was more common in women 55 to 84 years of age. CONCLUSIONS This study reports the population-based RVO incidence in Korea. The RVO incidence increased exponentially as the age of the population increased, and the RVO incidence in women was 1.28 times higher than that in men.

[1]  S. Taddei.  Blood pressure through aging and menopause , 2009, Climacteric : the journal of the International Menopause Society.

[2]  Roman G. Rubio,et al.  Myocardial infarction and cerebrovascular accident in patients with retinal vein occlusion. , 2011, Archives of ophthalmology.

[3]  K. Schulman,et al.  Resource use and costs of branch and central retinal vein occlusion in the elderly , 2010, Current medical research and opinion.

[4]  J. J. Wang,et al.  Prevalence and risk factors of retinal vein occlusion in an Asian population , 2008, British Journal of Ophthalmology.

[5]  P. Elliott,et al.  Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels , 2006, Journal of hypertension.

[6]  M. Alevizaki,et al.  Endogenous sex steroids and cardio- and cerebro-vascular disease in the postmenopausal period. , 2012, European journal of endocrinology.

[7]  T. Strandberg.  Cardiovascular disease and cancer in very old age , 2008, BMJ : British Medical Journal.

[8]  G. Logroscino,et al.  Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study , 2008, BMJ : British Medical Journal.

[9]  V. Howard,et al.  High prevalence of stroke symptoms among persons without a diagnosis of stroke or transient ischemic attack in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. , 2006, Archives of internal medicine.

[10]  I. Chatziralli,et al.  BRANCH RETINAL VEIN OCCLUSION: Epidemiology, Pathogenesis, Risk Factors, Clinical Features, Diagnosis, and Complications. An Update of the Literature , 2013, Retina.

[11]  R. Klein,et al.  Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies. , 2005, Ophthalmology.

[12]  T. Ninomiya,et al.  Nine-year incidence and risk factors for retinal vein occlusion in a general Japanese population: the Hisayama Study. , 2011, Investigative ophthalmology & visual science.

[13]  L. da Cruz,et al.  Pregnancy-associated retinal diseases and their management. , 2013, Survey of ophthalmology.

[14]  S. Inglis,et al.  Cardiovascular disease in women: implications for improving health outcomes. , 2012, Collegian.

[15]  P. Mitchell,et al.  Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. , 1996, Archives of ophthalmology.

[16]  W. Willett,et al.  Menopause and the risk of coronary heart disease in women. , 1987, The New England journal of medicine.

[17]  R. Klein,et al.  Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. , 2007, Ophthalmology.

[18]  Barbara Sternfeld,et al.  Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? , 2009, Journal of the American College of Cardiology.

[19]  F. Honrubia,et al.  Central retinal vein occlusion and HELLP syndrome. , 2000, Acta ophthalmologica Scandinavica.

[20]  Shih-Jen Chen,et al.  Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study , 2012, British Journal of Ophthalmology.

[21]  S. Gabsi,et al.  Occlusion du tronc de la veine centrale de la rétine chez une femme enceinte au 6e mois. , 1994 .

[22]  K. Park,et al.  Five Year Nationwide Incidence of Rhegmatogenous Retinal Detachment Requiring Surgery in Korea , 2013, PloS one.

[23]  R. Klein,et al.  Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. , 2008, Investigative ophthalmology & visual science.

[24]  A. Pries,et al.  Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. , 2011, Cardiovascular research.

[25]  H. Tunstall-Pedoe.  Myth and paradox of coronary risk and the menopause , 1998, The Lancet.

[26]  J Nyboe,et al.  Stroke incidence and risk factors for stroke in Copenhagen, Denmark. , 1988, Stroke.

[27]  D. Semple,et al.  Pre-eclampsia resulting in central retinal vein occlusion , 2006, Eye.

[28]  R. Klein,et al.  The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. , 2000, Transactions of the American Ophthalmological Society.

[29]  P. Prandoni,et al.  Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age‐related prospective cohort study , 2013, European journal of haematology.

[30]  D. Gustafson,et al.  Sex Differences in Stroke , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  J. Holmes,et al.  Risk factors of branch retinal vein occlusion. , 1985, Archives of ophthalmology.

[32]  P. Mitchell,et al.  Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. , 2006, Archives of ophthalmology.

[33]  H. van den Bussche,et al.  A comparative study demonstrated that prevalence figures on multimorbidity require cautious interpretation when drawn from a single database. , 2013, Journal of clinical epidemiology.

[34]  W. Ghali,et al.  A comprehensive view of sex-specific issues related to cardiovascular disease , 2007, Canadian Medical Association Journal.

[35]  M. Zimmerman,et al.  Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. , 1994, American journal of ophthalmology.

[36]  S. Hayreh.  Prevalent misconceptions about acute retinal vascular occlusive disorders , 2005, Progress in Retinal and Eye Research.

[37]  Herng‐Ching Lin,et al.  Seasonal variations in the occurrence of retinal vein occlusion: a five-year nationwide population-based study from Taiwan. , 2008, American journal of ophthalmology.

[38]  Tien Yin Wong,et al.  The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. , 2010, Ophthalmology.

[39]  J. Jonas,et al.  The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study. , 2013, Ophthalmology.

[40]  Ronald Klein,et al.  The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. , 2008, Archives of ophthalmology.

[41]  Mark D. Huffman,et al.  Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[42]  M. Larsen,et al.  Comorbidity in patients with branch retinal vein occlusion: case-control study , 2012, BMJ : British Medical Journal.

[43]  P. Mitchell,et al.  Natural history of central retinal vein occlusion: an evidence-based systematic review. , 2010, Ophthalmology.

[44]  Mark D. Huffman,et al.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[45]  T. Liesegang.  The epidemiology of retinal vein occlusion: The Beaver Dam Eye Study. Klein R, ∗ Klein BEK, Moss SE, Meuer SM. Tr Am Ophth Soc 2000;98:133–143. , 2001 .